SCHEMBL18286705

SCHEMBL18286705

Cc1c([SiH3])ccc2c1nc(C)n2C

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP2D6 P10635 1/20 0.39
KDM4E B2RXH2 5/20 0.38
ALDH1A1 P00352 4/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 4/20 0.36
RAB9A P51151 8/20 0.36
NPC1 O15118 7/20 0.36
SMN1; SMN2 Q16637 3/20 0.33
HSD17B10 Q99714 2/20 0.33
TP53 P04637 1/20 0.33
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
HDAC1 Q13547 1/20 0.31
HTT P42858 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14301805 0.80 CYP1A2 (0.44) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL16806045 0.77 CYP1A2 (0.39) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL2089942 0.77 CYP1A2 (0.39) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL6652856 0.69 FGFR1 (0.41) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL17561707 0.69 CYP1A2 (0.42) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL13135748 0.68 KDM4E (0.40) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL353025 0.68 CYP1A2 (0.59) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL10644015 0.68 KDM4E (0.49) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL24463614 0.67 CYP1A2 (0.37) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL614873 0.67 CYP1A2 (0.37) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2855453-B1 BENZIMIDAZOLE-PROLINE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2016-12-07 EP disclosed